Management of Patients With Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: 1-year Outcomes of The PERI-DYS Study

Learn more

Prospective evaluation of lipid management following acute coronary syndrome in Saudi Arabia

Learn more

Hypercholesterolemia Treatment Patterns and Lipid Target in ACS Patients: HYDRA-ACS Registry

Learn more

Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice

Learn more

Achievement of lipid modification goals with Statins & Ezetimibe

Learn more

Single-Pill Combinations in Dyslipidemia

This review describes the potential benefits of combination treatment and presents data supporting the use of single-pill combination (SPC) for increasing exposure to lipid-lowering treatment (LLT).

Learn more

Management of ASMD - Expert opinion: Professor Moeen Al Sayed

Professor Moeen gives a detailed explanation on how Olipudase Alfa acts in the body once administered.

Learn more

Navigating the Pompe Disease Journey

Recognizing key signs and symptoms along the way

Learn more

Meta Analysis of apoB Lowering and CV Risk Reduction Among Different LLTs

Galimberti F, et al. Poster presented at the 91^st European Atherosclerosis Society congress (EAS) 2023.

Learn more

Statin/ezetimibe SPC for better adherence to LLT

This large cohort study of patients from the Lombardy region (Italy) demonstrated that the single-pill combination of statin and ezetimibe substantially improved adherence to drug therapy vs the two-pill combination of respective drugs.

Learn more